What Happened? A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national ...

Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q2 ...

In the last three months, 5 analysts have published ratings on Dentsply Sirona (NASDAQ: XRAY), offering a diverse range of perspectives from bullish to bearish.

Q1 EPS of $0.43 beats $0.30 estimate; sales of $879 million top $854.75 million consensus. FY25 sales guidance raised to $3.60 billion–$3.70 billion; EPS reaffirmed at $1.80–$2.00. Last Chance: See ...

Potential shareholder lawsuits are swirling around Charlotte-based Dentsply Sirona Inc. since it disclosed an internal investigation into possible securities violations. One law firm is pitching for ...

A California appeals court has allowed a class-action lawsuit against Dentsply International that alleges dentists who purchased the company's popular Cavitron ultrasonic scaler were harmed because ...

The integration is made possible by Dentsply Sirona's newly released DS Core API (Application Programming Interface). The API ...

With significant upside potential, DENTSPLY SIRONA Inc. (NASDAQ:XRAY) secures a spot on our list of the 15 Best Robotics Stocks to Buy Under $20. At the Morgan Stanley 23rd Annual Global Healthcare ...

Oct 24 (Reuters) - (This Oct. 24 story has been corrected to say that Dentsply Sirona suspended sales of its 'Byte' teeth aligners, not all aligners in the headline) Dentsply Sirona (XRAY.O), opens ...

Healthcare distributor Patterson Companies (NASDAQ:PDCO) traded lower on Wednesday after dental product manufacturer Dentsply Sirona (NASDAQ:XRAY) said it decided against renewing the companies' ...